Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to -$1.3 million.

  • Ultralife's Change in Receivables rose 6346.6% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 71321.32%. This contributed to the annual value of -$7.6 million for FY2024, which is 29534.7% down from last year.
  • As of Q3 2025, Ultralife's Change in Receivables stood at -$1.3 million, which was up 6346.6% from -$3.9 million recorded in Q2 2025.
  • Ultralife's Change in Receivables' 5-year high stood at $6.6 million during Q1 2025, with a 5-year trough of -$4.2 million in Q2 2024.
  • Moreover, its 4-year median value for Change in Receivables was -$1.7 million (2021), whereas its average is -$352166.7.
  • Within the past 5 years, the most significant YoY rise in Ultralife's Change in Receivables was 20585.44% (2024), while the steepest drop was 20115.16% (2024).
  • Quarter analysis of 4 years shows Ultralife's Change in Receivables stood at -$2.0 million in 2021, then skyrocketed by 328.23% to $4.5 million in 2023, then plummeted by 178.05% to -$3.5 million in 2024, then soared by 63.56% to -$1.3 million in 2025.
  • Its Change in Receivables stands at -$1.3 million for Q3 2025, versus -$3.9 million for Q2 2025 and $6.6 million for Q1 2025.